Premier Path Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
1,557
-417
-21% -$115K 0.04% 333
2026
Q1
$583K Buy
1,974
+274
+16% +$81.4K 0.08% 239
2025
Q4
$464K Buy
1,700
+73
+4% +$19.8K 0.06% 262
2025
Q3
$440K Buy
1,627
+11
+0.7% +$2.99K 0.06% 273
2025
Q2
$445K Buy
1,616
+129
+9% +$35.1K 0.06% 267
2025
Q1
$394K Buy
1,487
+77
+5% +$19K 0.06% 263
2024
Q4
$327K Buy
1,410
+83
+6% +$19.1K 0.05% 293
2024
Q3
$293K Sell
1,327
-213
-14% -$44.1K 0.05% 303
2024
Q2
$303K Buy
1,540
+414
+37% +$85.5K 0.05% 290
2024
Q1
$242K Sell
1,126
-168
-13% -$35.3K 0.05% 303
2023
Q4
$259K Buy
+1,294
New +$276K 0.06% 284

Other funds holding CME

Premier Path Wealth Partners's CME Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its CME Group (CME) stake by 21% in Q2 2026, selling an estimated $115K and leaving 1,557 shares worth $344K. The position accounts for 0.04% of the portfolio, ranked #333.

Premier Path Wealth Partners first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $583K in Q1 2026. 629 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Premier Path Wealth Partners held 1,557 shares of CME Group worth $344K as of Q2 2026.
  • Premier Path Wealth Partners sold 417 CME Group shares in Q2 2026, an estimated $115K.
  • CME Group made up 0.04% of Premier Path Wealth Partners's portfolio in Q2 2026, its #333 holding.
  • Premier Path Wealth Partners first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Premier Path Wealth Partners's CME Group position peaked at $583K in Q1 2026.
  • 629 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.